Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer-Reference-Cited by-同舟云学术

Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer

Published:2024-07 Issue:7 Volume:9 Page:101507
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Sutera Philip^ORCID,Deek Matthew P.,Deek Rebecca A.,Guler Ozan Cem,Hurmuz Pervin,Reyhan Mehmet,Rowe Steven,Radwan Noura,Dipasquale Shirl,Hrinivich William T.,Lowe Kathryn,Ren Lei,Saraiya Biren,Ennis Ronald,Hathout Lara,Mayer Tina,Deweese Theodore L.,Song Daniel Y.,Kiess Ana,Oymak Ezgi,Pienta Kenneth,Feng Felix,Pomper Martin,Ozyigit Gokhan,Tran Phuoc T.,Onal Cem,Phillips Ryan M.

Publisher

Elsevier BV

Reference41 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer;de Wit;N Engl J Med,2019

3. Apalutamide and overall survival in prostate cancer;Smith;Eur Urol,2021

4. Enzalutamide and survival in nonmetastatic, castration-resistant prostate cancer;Sternberg;N Engl J Med,2020

5. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: Long-term survival results from the STAMPEDE trial;Clarke;Ann Oncol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics;Radiotherapy and Oncology;2024-10